Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Efficacy and Safety of a Chinese Herbal Medicine for the Constipation-predominant Irritable Bowel Syndrome (IBS-C): a Double-blinded, Placebo-controlled, Randomized Pilot Clinical Trial

NCT06319729 is registered in ClinicalTrials.gov with Hong Kong Baptist University as lead sponsor.

NCT NCT06319729
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06319729 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Efficacy and Safety of a Chinese Herbal Medicine for the Constipation-predominant Irritable Bowel Syndrome (IBS-C): a Double-blinded, Placebo-controlled, Randomized Pilot Clinical Trial
Lead sponsor
Hong Kong Baptist University
Phase
Phase 2
Overall status
Unknown status
Start date
March 25, 2024
Completion date
November 30, 2024
Enrollment
78 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

constipation-predominant irritable bowel syndrome